Literature DB >> 22412126

Palliative sedation: when and how?

Eduardo Bruera.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22412126     DOI： 10.1200/JCO.2011.41.1223

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  Changes in opinions on palliative sedation of palliative care specialists over 16 years and their effects on clinical practice.

Authors:  Sayaka Maeda; Tatsuya Morita; Masayuki Ikenaga; Hirofumi Abo; Yoshiyuki Kizawa; Satoru Tsuneto
Journal:  Support Care Cancer       Date:  2018-10-12       Impact factor: 3.603

Review 2.  Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life.

Authors:  Ahsan Azhar; David Hui
Journal:  Cancer Res Treat       Date:  2022-06-30       Impact factor: 5.036

3.  Unbearable suffering and requests for euthanasia prospectively studied in end-of-life cancer patients in primary care.

Authors:  Cees Dm Ruijs; Gerrit van der Wal; Ad Jfm Kerkhof; Bregje D Onwuteaka-Philipsen
Journal:  BMC Palliat Care       Date:  2014-12-23       Impact factor: 3.234

4.  Palliative sedation challenging the professional competency of health care providers and staff: a qualitative focus group and personal written narrative study.

Authors:  Danièle Leboul; Régis Aubry; Jean-Michel Peter; Victor Royer; Jean-François Richard; Frédéric Guirimand
Journal:  BMC Palliat Care       Date:  2017-04-11       Impact factor: 3.234

Review 5.  Delirium in Palliative Care.

Authors:  Patricia Bramati; Eduardo Bruera
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

6.  Sedation at the end of life - a nation-wide study in palliative care units in Austria.

Authors:  Sophie Schur; Dietmar Weixler; Christoph Gabl; Gudrun Kreye; Rudolf Likar; Eva Katharina Masel; Michael Mayrhofer; Franz Reiner; Barbara Schmidmayr; Kathrin Kirchheiner; Herbert Hans Watzke
Journal:  BMC Palliat Care       Date:  2016-05-14       Impact factor: 3.234
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.